回肠造口术的再入院相关因素分析

2017-01-20 MedSci MedSci原创

据报道,与其他手术患者相比,新回肠造口患者具有更高的再住院率,但是关于其相关预测因子的研究数据有限。近期,一项旨在评估新回肠造口术后再入院的原因和预测因素的研究发表在杂志Ann Surg上。这项研究在2个相关医院共统计了1114条记录,以确定患者进行的第一次回肠造口术。主要结果是在手术后60天内重新入院。研究采用多元逻辑回归分析识别独立预测因子;使用AUC曲线下面积评价二级分析中的年龄分层模型。此

据报道,与其他手术患者相比,新回肠造口患者具有更高的再住院率,但是关于其相关预测因子的研究数据有限。

近期,一项旨在评估新回肠造口术后再入院的原因和预测因素的研究发表在杂志Ann Surg上。

这项研究在2个相关医院共统计了1114条记录,以确定患者进行的第一次回肠造口术。主要结果是在手术后60天内重新入院。研究采用多元逻辑回归分析识别独立预测因子;使用AUC曲线下面积评价二级分析中的年龄分层模型。

此项研究结果显示:共有407例患者接受新回肠造口术;其中58%患有癌症,31%为IBD; 49%为LAR,27%为结肠切除术和14%为结肠切除术。中位住院时间为8天。在这些患者中,39%的患者返回医院,28%的患者在出院后中位数为12天时再次入院(n = 113)。再次入院的最常见原因是脱水(42%)、腹膜内感染(33%)和腹膜外感染(29%)。

脱水与晚期、更长时间和重复再入院相关。重复入院的独立重大预测因素为Clavien-Dindo并发症3〜4级[OR(比值比)6.7],Charlson共病指数(OR,1.4);较长的住院时间(OR ,0.5)和65岁或以上(OR ,0.4)是保护性的。

高于或低于65岁的队列分层显示年龄较大的患者再入院更能够被预测(AUC 0.84),具有更加可以预防的原因,而年轻患者再入院难以预测或预防(AUC 0.65)。

此项研究结果个表明:再入院最常见的原因是由脱水,而严重的并发症、合并症负担、循环造口、住院时间较短和年龄可以预测再入院。老年患者的再入院更容易被预测。

原始出处:
Fish DR, Mancuso CA, Garcia-Aguilar JE, Lee SW, Nash GM, Sonoda T, Charlson ME, Temple LK.Readmission After Ileostomy Creation: Retrospective Review of a Common and Significant Event.Ann Surg. 2017 Feb;265(2):379-387.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1457454, encodeId=94a5145e45440, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Sun Jan 22 04:34:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511335, encodeId=7612151133529, content=<a href='/topic/show?id=d47d40542cc' target=_blank style='color:#2F92EE;'>#回肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40542, encryptionId=d47d40542cc, topicName=回肠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b1110335485, createdName=Tamikia, createdTime=Sun Jan 22 04:34:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585222, encodeId=b053158522254, content=<a href='/topic/show?id=08aa949e01c' target=_blank style='color:#2F92EE;'>#造口术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94970, encryptionId=08aa949e01c, topicName=造口术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8b17134701, createdName=wjcjjian, createdTime=Sun Jan 22 04:34:00 CST 2017, time=2017-01-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1457454, encodeId=94a5145e45440, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Sun Jan 22 04:34:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511335, encodeId=7612151133529, content=<a href='/topic/show?id=d47d40542cc' target=_blank style='color:#2F92EE;'>#回肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40542, encryptionId=d47d40542cc, topicName=回肠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b1110335485, createdName=Tamikia, createdTime=Sun Jan 22 04:34:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585222, encodeId=b053158522254, content=<a href='/topic/show?id=08aa949e01c' target=_blank style='color:#2F92EE;'>#造口术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94970, encryptionId=08aa949e01c, topicName=造口术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8b17134701, createdName=wjcjjian, createdTime=Sun Jan 22 04:34:00 CST 2017, time=2017-01-22, status=1, ipAttribution=)]
    2017-01-22 Tamikia
  3. [GetPortalCommentsPageByObjectIdResponse(id=1457454, encodeId=94a5145e45440, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Sun Jan 22 04:34:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511335, encodeId=7612151133529, content=<a href='/topic/show?id=d47d40542cc' target=_blank style='color:#2F92EE;'>#回肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40542, encryptionId=d47d40542cc, topicName=回肠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b1110335485, createdName=Tamikia, createdTime=Sun Jan 22 04:34:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585222, encodeId=b053158522254, content=<a href='/topic/show?id=08aa949e01c' target=_blank style='color:#2F92EE;'>#造口术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94970, encryptionId=08aa949e01c, topicName=造口术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8b17134701, createdName=wjcjjian, createdTime=Sun Jan 22 04:34:00 CST 2017, time=2017-01-22, status=1, ipAttribution=)]

相关资讯

2016 ENETS共识指南:空肠和回肠神经内分泌肿瘤(更新版)

2016年1月,欧洲神经内分泌肿瘤学会(ENETS)更新发布了空肠和回肠神经内分泌肿瘤共识指南,本文是对2012版ENETS指南的更新,目的是为了进一步规范和改善空回肠神经内分泌肿瘤的早期诊断和治疗。全文获取:下载地址:指南下载(需要扣积分2分, 梅斯医学APP免积分下载)